Gene · 1871
Papers3,808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,808
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment. | Cancers (Basel) | 2022 | 36612077 | PubTator, text mining | PubMed |
| Human Placental Endothelial Cell and Trophoblast Heterogeneity and Differentiation Revealed by Single-Cell RNA Sequencing. | Cells | 2022 | 36611882 | PubTator, text mining | PubMed |
| The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma. | Front Immunol | 2022 | 36601121 | PubTator, text mining | PubMed |
| RNaseH2A downregulation drives inflammatory gene expression via genomic DNA fragmentation in senescent and cancer cells. | Commun Biol | 2022 | 36577784 | PubTator, text mining | PubMed |
| BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, β-catenin- and MGMT-dependent apoptotic cell death. | Cell Commun Signal | 2022 | 36575468 | PubTator, text mining | PubMed |
| TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study. | Front Genet | 2022 | 36568387 | PubTator, text mining | PubMed |
| Turbulence of glutamine metabolism in pan-cancer prognosis and immune microenvironment. | Front Oncol | 2022 | 36568190 | PubTator, text mining | PubMed |
| The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets. | Front Oncol | 2022 | 36561529 | PubTator, text mining | PubMed |
| Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes. | Int J Mol Sci | 2022 | 36555712 | PubTator, text mining | PubMed |
| cfDNA Methylation Profiles and T-Cell Differentiation in Women with Endometrial Polyps. | Cells | 2022 | 36552753 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| Identification of the Transcriptional Regulatory Role of RUNX2 by Network Analysis in Lung Cancer Cells. | Biomedicines | 2022 | 36551878 | PubTator, text mining | PubMed |
| Application of Extracellular Vesicles in Gynecologic Cancer Treatment. | Bioengineering (Basel) | 2022 | 36550946 | PubTator, text mining | PubMed |
| MicroRNAs within the Basal-like signature of Quadruple Negative Breast Cancer impact overall survival in African Americans. | Sci Rep | 2022 | 36550153 | PubTator, text mining | PubMed |
| Role of circular RNAs in retinoblastoma. | Funct Integr Genomics | 2022 | 36547723 | PubTator, text mining | PubMed |
| A review of current evidence about lncRNA MEG3: A tumor suppressor in multiple cancers. | Front Cell Dev Biol | 2022 | 36544907 | PubTator, text mining | PubMed |
| Increased expression of miR-194-5p through the circPVRL3/miR-194-5p/SOCS2 axis promotes proliferation and metastasis in pancreatic ductal adenocarcinoma by activating the PI3K/AKT signaling pathway. | Cancer Cell Int | 2022 | 36539807 | PubTator, text mining | PubMed |
| Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. | Sci Rep | 2022 | 36539545 | PubTator, text mining | PubMed |
| Non-coding RNA-related antitumor mechanisms of marine-derived agents. | Front Pharmacol | 2022 | 36532760 | PubTator, text mining | PubMed |
| Targeting glycolysis in non-small cell lung cancer: Promises and challenges. | Front Pharmacol | 2022 | 36532721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1871/papers?page=23